Agilon Health (NYSE:AGL) Reaches New 52-Week High – Here’s Why

Shares of Agilon Health, Inc. (NYSE:AGL) reached a new 52-week high on Thursday . The company traded as high as $109.49 and last traded at $102.08, with a volume of 295802 shares. The stock had previously closed at $102.16.

Analyst Ratings Changes

A number of analysts have commented on the company. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $33.00 to $49.00 in a report on Thursday, May 7th. Wells Fargo & Company reissued an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. Weiss Ratings lowered Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Finally, Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $58.73.

Agilon Health Trading Down 0.1%

The company has a market capitalization of $1.70 billion, a P/E ratio of -4.73 and a beta of 3.02. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a fifty day moving average price of $52.96 and a 200-day moving average price of $29.40.

Agilon Health (NYSE:AGL) last released its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. On average, equities research analysts anticipate that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

Several institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Agilon Health by 3.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after acquiring an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its holdings in shares of Agilon Health by 28.4% in the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares in the last quarter. Apollon Wealth Management LLC grew its holdings in shares of Agilon Health by 17.4% in the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after acquiring an additional 12,193 shares in the last quarter. Legal & General Group Plc grew its holdings in Agilon Health by 4.1% during the second quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock valued at $796,000 after purchasing an additional 13,700 shares during the period. Finally, Symphony Financial Services Inc. grew its holdings in Agilon Health by 51.6% during the third quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock valued at $48,000 after purchasing an additional 16,000 shares during the period.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.